SNDL (NASDAQ:SNDL) Bolsa

SNDL

SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.

WIIM

GM shares are trading higher, rebounding after falling Tuesday on Q2 financial results.

When a person becomes eligible for <a href="https://www.benzinga.com/money/social-security-vs-retirement-benefits">Social Security Disability Insurance</a>, it's often seen as a financial lifeline. But in some cases, the benefits can create unexpected challenges — especially when they affect access to other types of assistance. That's exactly what one stage 4 cancer patient in Minnesota is facing.
She turned to the <a href="https://www.reddit.com/r/SocialSecurity/comments/1lyvljl/can_i_turn_down_some_of_my_ss_disability/">r/SocialSecurity subreddit</a> with a difficult question: Can I decline part of my SSDI in order to stay on state-subsidized health insurance?
Let's break down what's going on and what options may exist.
Don't Miss:
<ul class="wp-block-list">
<li>7,000+ investors have joined Timeplast's mission to eliminate microplastics—now it's your turn to <a href="https://www.benzinga.com/money/timeplast-advertorial">invest in the future of sustainable plastic before time runs out.</a></li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
<h2 class="wp-block-heading">Two Checks, Two Problems?</h2>
In her post, the woman explained she receives two monthly Social Security payments: one disability payment based on her own work history — about $1,100 — and another payment based on her late husband's — about $1,600. This second payment pushed her total income above the limit for MinnesotaCare, the state's public health insurance program.
She says that when she initially applied for MinnesotaCare, she only reported the $1,100 payment because that was all she had been approved for at the time. But once the second benefit kicked in, she was informed she no longer qualified for subsidized coverage, leaving her with the high costs of private insurance during a serious medical crisis.
So, she asked: "Can I turn down part of my Social Security benefits in any way? Is there any way to alter my payments so I can afford health insurance again? Or is that considered fraud?"
Trending: This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a>
<h2 class="wp-block-heading">Can You Refuse SSDI or Survivor Benefits?</h2>
According to commenters familiar with Social Security rules, the answer is no: You can't pick and choose parts of your SSDI payment. Social Security calculates your full benefit amount based on your earnings or a spouse's, and once approved, you receive what you&#8217;re due by law.
One commenter added that if she's receiving both her own and her late husband&#8217;s benefits, this might actually be a mistake. "You don&#8217;t get two checks," they wrote. "You get either your earnings or your husband&#8217;s." Someone else chimed in that if an <a href="https://www.benzinga.com/personal-finance/management/25/06/45987399/35-year-old-woman-shocked-by-5000-social-security-overpayment-notice-says-she-never-received-benefits">overpayment</a> is happening, Social Security may request the money back later. The SSA <a href="https://www.ssa.gov/faqs/en/questions/KA-01861.html">confirms</a> that beneficiaries cannot receive disability benefits and retirement benefits at the same time. Typically, disability payments will automatically change to retirement payments when the beneficiary reaches full retirement age.&nbsp;
However, according to <a href="https://www.usa.gov/social-security-disability">USAGov</a>, beneficiaries may be able to receive Supplemental Security Income and retirement benefits at the same time. This makes it especially important to confirm what type of benefits are being paid — and whether both should be.
See Also: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a>
<h2 class="wp-block-heading">Minnesota Resources Might Help</h2>
While adjusting SSDI benefits may not be an option, the Reddit community did offer some practical advice. Several users recommended contacting <a href="https://disabilityhubmn.org/">Disability Hub MN</a>, a state-supported resource center that helps Minnesotans with disabilities understand their options.
"This is exactly the kind of situation they exist for," one person said. "Very knowledgeable, very patient, also great at explaining the chaotic health care system so it makes sense to us lay people."
Another suggested looking into buy-in programs for Medicaid or similar coverage for people with disabilities who earn too much for standard programs. In some states, including Minnesota, these allow people to pay a monthly premium to access Medicaid benefits — potentially providing a more affordable path to coverage.
<h2 class="wp-block-heading">Bottom Line</h2>
<a href="https://www.benzinga.com/25/05/45601283/social-security-checks-could-shrink-for-450000-retirees-as-government-resumes-seizing-benefits-over-student-loan-defaults">Social Security benefits</a>, once approved, generally can't be partially declined or reduced by request. If you're receiving SSDI or survivor benefits and find that your income disqualifies you from other help, consider exploring state-level programs that may offer affordable alternatives.
If you live in Minnesota, calling Disability Hub MN could be a smart first step. And if you're unsure about the accuracy of your benefit payments, contact the SSA directly to help clarify what you&#8217;re receiving and whether any corrections need to be made.
Read Next: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?
Image: Shutterstock

Personal Finance

Stage 4 Cancer Patient Wonders: Can I Turn Down SSDI To Keep My Health Coverage?

"You'd have to be very skilled to have a job," said AI godfather Geoffrey Hinton, warning that automation could erase much of today's intellectual labor. As generative AI floods workplaces, Hinton's comments highlight growing uncertainty about the future of work.
Speaking on "<a href="https://www.youtube.com/watch?v=giT0ytynSqg">The Diary of a CEO</a>" podcast, Hinton argued that automation will swallow "mundane intellectual labor" yet <a href="https://www.businessinsider.com/geoffrey-hinton-godfather-of-ai-safe-jobs-2025-6">spare medicine</a>, where demand seems bottomless. The bold claim invites a pressing question: Can health care outrun algorithms while other sectors shrink?
<h2 class="wp-block-heading">Experts Diverge On AI Job Loss</h2>
Hinton's forecast follows a grim pattern. Anthropic CEO Dario Amodei <a href="https://www.axios.com/2025/05/28/ai-jobs-white-collar-unemployment-anthropic">told</a> Axios in May that AI could erase "roughly half" of entry‑level white‑collar roles within one to five years, warning unemployment could spike to 10% to 20%.
Don't Miss:
<ul class="wp-block-list">
<li>Be part of the breakthrough that could replace plastic as we know it—<a href="https://www.benzinga.com/money/timeplast-advertorial">invest in Timeplast before the July 31st deadline and help revolutionize a $1.3T industry.</a></li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
Jensen Huang, CEO of Nvidia (NASDAQ: NVDA), pushed back. Huang <a href="https://www.axios.com/2025/07/14/ai-jobs-nvidia-jensen-huang-dario-amodei">told </a>Axios last week that AI will "create vastly more and superior jobs," comparing the shift to past industrial leaps.
Even inside boardrooms, consensus proves elusive. Salesforce (NYSE: CRM) CEO Marc Benioff, <a href="https://www.businessinsider.com/marc-benioff-ai-white-collar-jobs-salesforce-2025-7#:~:text=Marc%20Benioff%20says%20the%20narrative%20that%20AI,white%2Dcollar%20jobs%20is%20wrong&amp;text=AI%20is%20radically%20reshaping%20business,radical%20augmentation%20of%20the%20workforce.%22">told</a> Business Insider at the AI for Good Global Summit in Geneva in July that customers are "not saying, ‘I'm laying off employees because of AI advancements.' He cast the technology as a productivity booster, not a job killer
Goldman Sachs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) <a href="https://www.goldmansachs.com/insights/articles/generative-ai-could-raise-global-gdp-by-7-percent">research</a> from 2023 forecasts that generative AI could eventually automate up to 50% of tasks and boost global output by nearly $7 trillion.
<h2 class="wp-block-heading">Health Care Emerges As Automation Outlier</h2>
Hinton told Steven Bartlett, host of &#8220;The Diary of a CEO&#8221; podcast, that clinical work is "much more elastic" because patients always want more treatment when costs falls. He estimated that making doctors five times more efficient would yield five times more care, not layoffs.
Trending: This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a>
Data align with this view. A 2024<a href="https://www.mckinsey.com/mgi/our-research/generative-ai-and-the-future-of-work-in-america"> McKinsey report</a> predicted automation could replace up to 30% of U.S. jobs by 2030 and projected net hiring growth in health care, clean energy, and STEM fields. The consultancy pointed to tasks that remain difficult to automate, such as sterilizing surgical tools and assisting with in-home care.
"I think there&#8217;s something about the human empathy aspect of that and the care and so on, that&#8217;s particularly humanistic," Google DeepMind CEO Demis Hassabis <a href="https://www.wired.com/video/watch/big-interview-demis-hassabis-on-the-future-of-work-in-the-age-of-ai">told</a> Wired in an interview when asked whether hospitals will adopt robot nurses.
Investors appear convinced. Health‑tech startups attracted $6.4 billion in the first half of the year, up7% from 2024, according to<a href="https://rockhealth.com/insights/h1-2025-market-overview-proof-in-the-pudding"> Rock Health</a>.
See Also: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
<h2 class="wp-block-heading">Early Data Underscore Medical Demand</h2>
Recent labor figures reinforce the trend.<a href="https://www.bls.gov/news.release/pdf/empsit.pdf"> Bureau of Labor Statistics</a> data show health‑care payrolls grew by 39,000 in June, extending a 16‑month hiring streak even as overall job creation slowed.
Usage patterns reveal a disconnect between employees and leadership. According to the <a href="https://www.mckinsey.com/capabilities/mckinsey-digital/our-insights/superagency-in-the-workplace-empowering-people-to-unlock-ais-full-potential-at-work">report</a> "Superagency in the Workplace: Empowering People to Unlock AI's Full Potential," released in January by McKinsey, 12% of employees use generative AI for at least 30% of their daily work—more than triple what executives estimate. The report urges organizations to scale training and adoption efforts to fully unlock AI's potential in the workplace.
Read Next: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
Image: Shutterstock

News

'You'd Have to Be Very Skilled to Have A Job': AI Godfather Geoffrey Hinton Predicts Healthcare Will Survive AI Disruption

Selling is a critical skill that can help you make more money, advance in your career, and be persuasive outside of your career. This skill isn't only good for salespeople. Good selling can help you negotiate a higher salary, become more effective at conflict resolution, and find creative solutions to problems.
Financial personality Ramit Sethi recently shared some advice for people who want to get good at sales. While scripts can be useful, Sethi suggests seeing salespeople in action.
"If you want to get really good at sales, you have to put yourself in opportunities to get SOLD," Sethi said in a recent <a href="https://x.com/ramit/status/1944826941422383315">X post</a>.
Don't Miss:
<ul class="wp-block-list">
<li>7,000+ investors have joined Timeplast's mission to eliminate microplastics—now it's your turn to <a href="https://www.benzinga.com/money/timeplast-advertorial">invest in the future of sustainable plastic before time runs out.</a></li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
Here's how you can use Sethi's advice to get better at sales.
<h2 class="wp-block-heading">Put Yourself In Opportunities To Get Sold</h2>
You are the average of the five people who you spend the most time with. If you're intentionally surrounding yourself with salespeople, you'll get a better understanding of what works and what doesn't.&nbsp;
Each time you leave your house and go to any business, such as a grocery store or retail store, you're getting sold. Pay attention to how it's happening. Does the salesperson introduce a special deal at checkout? How do they treat you when you show up to buy? How do you feel during the interaction?
Asking yourself questions like these and monitoring your thoughts along the way can help you learn about sales. If you are conscious of your thoughts during the selling process, you can determine what moves you along the customer journey and what causes you to lose interest in a salesperson or a business.
Trending: This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a>
<h2 class="wp-block-heading">Learn From People In Multiple Industries</h2>
Selling is universal. Every business has to practice good selling to remain financially solvent. You don't have to limit yourself to one industry when learning from salespeople in action.&nbsp;
However, you can also learn from people who cater to different customer avatars. A cheap restaurant may use different selling strategies than a high-end restaurant. Someone who is selling a $7 training course may speak about their product differently compared to someone who is selling a $2,000 training course.
You can also learn new insights by going through people's funnels and seeing how they present their offers. You don't have to buy their products and services, but it is valuable to see how they deliver the entire experience.
See Also: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
<h2 class="wp-block-heading">Apply It To Your Selling</h2>
You can always learn more about selling by seeing other people in action and noticing how they make you feel. You'll get a better idea of what you like and don't like as a consumer, and you can apply those experiences to your own selling.
After listening to a salesperson do their presentation, write down some notes to remember the experience, even if it was bad. However, it's important to consider your customer avatar while deciding which selling tactics to use. If you sell Toyotas and spoke with someone who sells Lamborghinis, you may have to modify some of that salesperson's strategies for your core audience.&nbsp;
Listening to other salespeople and going through their funnels will improve your selling skills. When you test their ideas, it's important to remember that your approach to sales is never a finished product. You have to review important metrics, such as conversion rates and the average lifetime value per customer, to determine if your selling is effective. It's also important to monitor any changes to those metrics and adjust your selling accordingly. People change, and you have to change with them if the data suggests that's the right decision.
Read Next: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a>
Image: Shutterstock

Forget Scripts—Ramit Sethi Says This Is the Best Way To Learn Sales

Thermo Fisher Scientific Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) on Wednesday reported second-quarter 2025 adjusted earnings of $5.36 per share,&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">beating the street view of $5.23</a>.
Quarterly sales of $10.86 billion increased 3% year-over-year, beating the analyst consensus estimate of $10.68 billion. Organic revenue growth was 2%.
&#8220;The agility of our organization, powered by the PPI Business System, allowed us to effectively adapt to current market conditions, actively manage our cost base and deliver strong operational results in the second quarter,&#8221; said Marc Casper, chairman, president and <a href="https://www.benzinga.com/pressreleases/25/07/b46566528/thermo-fisher-scientific-reports-second-quarter-2025-results" target="_blank" rel="noreferrer noopener">CEO of Thermo Fisher Scientific</a>.
The company said, &#8220;PPI is helping us adjust our supply chains in the tariff environment and to actively manage our cost base.&#8221;
Also Read: <a href="https://www.benzinga.com/markets/equities/25/05/45643874/thermo-fisher-scientific-stock-big-upside-potential-after-sluggishness-through-november" target="_blank" rel="noreferrer noopener">Thermo Fisher Scientific Stock: Big Upside Potential After Sluggishness Through November?</a>
Management Change: Thermo Fisher Scientific announced Stephen Williamson, senior vice president and CFO, has decided to retire from the company, effective March 31, 2026.
The company&#8217;s board of directors appointed Jim Meyer, vice president of financial operations, to succeed Williamson as CFO, <a href="https://www.benzinga.com/pressreleases/25/07/b46570556/thermo-fisher-scientifics-chief-financial-officer-stephen-williamson-to-retire-in-early-2026" target="_blank" rel="noreferrer noopener">effective March 1, 2026</a>.
Guidance: During an earnings conference call, Thermo Fisher Scientific forecasts 2025 revenue of $43.6 billion-$44.2 billion, compared to prior guidance of $43.3 billion-$44.2 billion and the consensus of $43.71 billion.
The company expects adjusted earnings of $22.22-$22.84&nbsp;per share, compared to <a target="_blank" href="https://www.benzinga.com/general/health-care/25/04/44966173/thermo-fisher-beats-q1-estimates-lowers-full-year-forecast-as-tariffs-and-costs-take-a-toll" rel="noreferrer noopener">prior guidance of $21.76-$22.84</a> and consensus of $22.33. The company adds that the U.S.-China tariff situation has improved significantly compared to prior assumptions.
Last week, Thermo Fisher Scientific announced an expansion of its strategic partnership with Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) to enable additional U.S. drug product manufacturing. The terms of the deal <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/b46439260/thermo-fisher-scientific-and-sanofi-expand-strategic-partnership-to-enable-additional-u-s-drug-pro" rel="noreferrer noopener">were not disclosed</a>.
Under the agreement, Thermo Fisher will acquire Sanofi&#8217;s steriles manufacturing site in Ridgefield, New Jersey, and continue to manufacture a portfolio of therapies for Sanofi.
In addition, Thermo Fisher will expand use of the site to meet the growing demand from pharma and biotech customers for U.S. manufacturing capacity.
The Ridgefield site is a sterile fill-finish and packaging facility with over 200 employees who will join Thermo Fisher following the completion of the transaction.
The transaction is expected to be completed in the second half of 2025. Upon completion of the transaction, Sanofi&#8217;s Ridgefield facility will become part of Thermo Fisher&#8217;s pharma services business within its Laboratory Products and Biopharma Services segment.
Price Action: TMO stock is up 13.2% at $483.94 at the last check on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46568747/carvana-stock-outlook-cautious-optimism-warranted" target="_blank" rel="noreferrer noopener">Carvana Stock Outlook: Cautious Optimism Warranted</a></li>
</ul>
Photo: Shutterstock

Earnings

Large Cap

Guidance

Health Care

Management

Movers

Trading Ideas

General

Why Thermo Fischer Stock Is Rising Wednesday

The Sherwin-Williams Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) reported worse-than-expected second-quarter earnings results and cut its FY25 EPS and adjusted EPS guidance below <a href="https://www.benzinga.com/quote/SHW/earnings">estimates on Tuesday</a>.
The American paints and coatings company reported quarterly adjusted earnings per share of $3.38, below the Wall Street view of $3.81. Quarterly revenue of $6.31 billion beat the analyst consensus of $6.30 billion.
Sherwin-Williams expects third-quarter revenue to be up or down a low-single-digit percentage compared to the third quarter of 2024.
The company lowered its 2025 adjusted EPS guidance to $11.20-$11.50 (prior $11.65-$12.05), compared to the $11.88 analyst consensus estimate. It expects consolidated net sales to be up or down by a low single-digit percentage compared to full-year 2024 (prior low single-digit percentage range).
Sherwin-Williams lowered 2025 GAAP EPS guidance to $10.11-$10.41 (prior $10.70-$11.10) versus $11.09 analyst consensus estimate.
Sherwin-Williams shares gained 1% to trade at $343.45 on Wednesday.
These analysts made changes to their price targets on Sherwin-Williams following earnings announcement.
<ul class="wp-block-list">
<li>Wells Fargo analyst Michael Sison maintained Sherwin-Williams with an Overweight rating and lowered the price target from $420 to $400.</li>
<li>JP Morgan analyst Jeffrey Zekauskas maintained the stock with an Overweight rating and lowered the price target from $390 to $378.</li>
<li>Citigroup analyst Patrick Cunningham maintained Sherwin-Williams with a Neutral and lowered the price target from $385 to $375.</li>
</ul>
Considering buying SHW stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/SHW/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="608" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23125431/image-337-1024x608.png" alt="" class="wp-image-997616" style="width:598px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23125431/image-337-1024x608.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23125431/image-337-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23125431/image-337-768x456.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23125431/image-337.png 1092w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/07/46541326/wall-streets-most-accurate-analysts-weigh-in-on-3-industrials-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Industrials Stocks With Over 5% Dividend Yields</a></li>
</ul>
Photo via Shutterstock

Price Target

Markets

Analyst Ratings

Sherwin-Williams Analysts Slash Their Forecasts After Downbeat Q2 Earnings

B. Riley Securities analyst Craig Ellis maintains Rigetti Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) with a Buy and raises the price target from $15 to $19.

RGTI

B. Riley Securities Maintains Buy on Rigetti Computing, Raises Price Target to $19

Citigroup analyst Jason Bazinet maintains Unity Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) with a Buy and raises the price target from $29 to $44.

Citigroup Maintains Buy on Unity Software, Raises Price Target to $44

B. Riley Securities analyst Craig Ellis maintains D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) with a Buy and raises the price target from $20 to $22.

QBTS

B. Riley Securities Maintains Buy on D-Wave Quantum, Raises Price Target to $22

Citigroup analyst Jason Bazinet maintains Take-Two Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) with a Buy and raises the price target from $260 to $270.

TTWO

Citigroup Maintains Buy on Take-Two Interactive, Raises Price Target to $270

Citigroup analyst Jason Bazinet maintains Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Buy and raises the price target from $123 to $152.

RBLX

Citigroup Maintains Buy on Roblox, Raises Price Target to $152

WNEB

Western New England shares are trading higher after the company reported better-than-expected Q2 EPS results.

Citigroup analyst Vijit Jain maintains MakeMyTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) with a Buy and lowers the price target from $125 to $120.

MMYT

Citigroup Maintains Buy on MakeMyTrip, Lowers Price Target to $120

Raymond James analyst Andy Marck downgrades Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) from Strong Buy to Outperform and raises the price target from $81 to $130.

Downgrades

Raymond James Downgrades Roblox to Outperform, Raises Price Target to $130

OPXS

Optex Systems Holdings shares are trading higher after the company announced it has been awarded a five-year Army contract worth up to $10.2 million for its optical sighting system.

A new plan to make the U.S. the powerhouse in the <a href="https://www.benzinga.com/topic/artificial-intelligence">artificial intelligence sector </a>and win the global AI race could make several tech giants stand out, according to tech analyst Dan Ives.
Here are Ives&#8217; picks and why he thinks the push into AI is so important now.
What Happened: <a href="https://www.benzinga.com/news/large-cap/25/01/43106379/trump-reverses-bidens-ai-policies-on-day-1-what-it-means-for-tech-giants-nvidia-amd-alphabet">Since being inaugurated</a> in January, President Donald Trump has placed an emphasis on artificial intelligence. He unveiled new details of an &#8220;AI Action Plan&#8221; on Wednesday that he says will help the U.S. in "Winning the AI Race."
Wednesday's event features Trump and CEOs of several companies across the AI, infrastructure and reindustrialization topics covered in the presentation. Among the key speakers are Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) CEO Lisa Su, Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) CTO Shyam Sankar and MP Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) CEO James Litinsky.
According to Ives, the so-called AI Action Plan is set to focus on the three main areas: the buildout of AI infrastructure, regulation and global influence.
"The Trump keynote will likely aim at outlining a national AI strategy while targeting aggressive plans to accelerate chip exports reflecting the new administration's elevated focus on winning the AI race against foreign adversaries," Ives said.
The analyst said the fast-track of deploying U.S.-made AI chips to partner nations and easing regulations for data center buildouts could be key topics covered by the president.
Read Also: <a href="https://www.benzinga.com/markets/tech/25/07/46487059/trump-white-house-to-crack-down-on-woke-ai-with-executive-order-targeting-political-bias-in-government-contracted-chatbots-and-models-report">Trump White House To Crack Down On &#8216;Woke AI&#8217; With Executive Order Targeting Political Bias In Government-Contracted Chatbots And Models: Report</a>
The AI Action Plan Winners: Ives expects tech stocks to likely see a "major move higher" in the second half of 2025.
"We have barely scratched the surface of this 4th Industrial Revolution now playing out around the world led by the Big Tech stalwarts," Ives said.
Among the big tech stalwarts that are expected to benefit from the AI Action Plan and 4th Industrial Revolution are:
<ul class="wp-block-list">
<li>NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)</li>
<li>Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>)</li>
<li>Palantir Technologies</li>
<li>Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)</li>
<li>Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)</li>
<li>Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)</li>
</ul>
Ives six stock picks include five of the Magnificent 7 stocks, leaving out Apple and Tesla. The analyst adds Palantir to the mix of the top picks for the AI Action Plan and AI Revolution.
The six companies are the tech winners "in this golden age," Ives said.
"This Trump speech will outline the foundation for US beating China in this AI Arms Race with Big Tech stalwarts playing a major role led by the Godfather of AI Jensen and Nvidia."
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46463595/dan-ives-picks-5-stocks-for-2nd-half-of-2025-nvidia-palantir-microsoft-and-more-golden-age-of-tech-is-here-with-ai-revolution">Dan Ives Picks 5 Stocks For 2nd Half Of 2025: Nvidia, Palantir, Microsoft And More: &#8216;Golden Age Of Tech Is Here With AI Revolution&#8217;</a></li>
</ul>
Image: Shutterstock

Analyst Color

Tech

AMZN

GOOG

GOOGL

MSFT

NVDA

PLTR

Trump's AI Action Plan To Unleash '4th Industrial Revolution': Dan Ives Picks 6 Stock Winners

FFIN

First Financial Bank Announces The Promotion Of Kyle Mcvey To Executive Vice President And Chief Financial Officer

Citigroup analyst Patrick Cunningham maintains Sherwin-Williams (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) with a Neutral and lowers the price target from $385 to $375.

Citigroup Maintains Neutral on Sherwin-Williams, Lowers Price Target to $375

Take-Two Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) has outperformed the market over the past 15 years by 10.54% on an annualized basis producing an average annual return of 22.88%. Currently, Take-Two Interactive has a market capitalization of $42.07 billion. 
Buying $1000 In TTWO: If an investor had bought $1000 of TTWO stock 15 years ago, it would be worth $22,182.70 today based on a price of $230.02 for TTWO at the time of writing.
<h3>Take-Two Interactive's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753289115_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Take-Two Interactive Stock In The Last 15 Years

B. Riley Securities analyst Yuan Zhi reiterates Mirion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MIR#NYSE">MIR</a>) with a Buy and raises the price target from $17 to $22.

Comments

SNDL

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL